Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis

Gatifloxacin Pharmacokinetics/Pharmacodynamics-based Optimal Dosing for Pulmonary and Meningeal Multidrug-resistant Tuberculosis

<br><strong>Background: </strong>Gatifloxacin is used for the treatment of multidrug-resistant tuberculosis (MDR-TB). The optimal dose is unknown.</br> <br><strong>Methods: </strong>We performed a 28-day gatifloxacin hollow-fiber system model of tuberculosi...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Deshpande, D, Pasipanodya, JG, Srivastava, S, Bendet, P, Koeuth, T, Bhavnani, SM, Ambrose, PG, Smythe, W, McIlleron, H, Thwaites, GE, Gumusboga, M, Van Deun, A, Gumbo, T
Format:	Journal article
Język:	English
Wydane:	Oxford University Press 2018

Podobne zapisy

Levofloxacin pharmacokinetics/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis
od: Deshpande, D, i wsp.
Wydane: (2018)

Randomized pharmacokinetic and pharmacodynamic comparison of fluoroquinolones for tuberculous meningitis.
od: Thwaites, G, i wsp.
Wydane: (2011)

Pharmacokinetics and pharmacodynamics of intensive antituberculosis treatment of tuberculous meningitis
od: Ding, J, i wsp.
Wydane: (2020)

Pharmacokinetics of antiretroviral drugs in infancy
od: Helen McIlleron, i wsp.
Wydane: (2009-12-01)

Effects on the QT Interval of a Gatifloxacin-Containing Regimen versus Standard Treatment of Pulmonary Tuberculosis
od: Olliaro, P, i wsp.
Wydane: (2017)

Minocycline intra-bacterial pharmacokinetic hysteresis as a basis for pharmacologic memory and a backbone for once-a-week pan-tuberculosis therapy
od: Devyani Deshpande, i wsp.
Wydane: (2022-10-01)

Physiologically-Based Pharmacokinetic Modelling to Predict the Pharmacokinetics and Pharmacodynamics of Linezolid in Adults and Children with Tuberculous Meningitis
od: Carlijn H. C. Litjens, i wsp.
Wydane: (2023-04-01)

Neuropsychiatric toxicity and cycloserine concentrations during treatment for multidrug-resistant tuberculosis
od: Richard Court, i wsp.
Wydane: (2021-04-01)

Comparative Study of Ocular Pharmacokinetics of Topical 0.3% Gatifloxacin Eye Gel and Solution in Rabbits
od: Manli Liu, i wsp.
Wydane: (2022-04-01)

A model-based approach for a practical dosing strategy for the short, intensive treatment regimen for paediatric tuberculous meningitis
od: Roeland E. Wasmann, i wsp.
Wydane: (2023-04-01)

Clinical pharmacokinetics and pharmacodynamics and pharmacodynamics of artemether-lumefantrine.
od: White, N, i wsp.
Wydane: (1999)

Getting drug doses right in children with tuberculosis (TB)
od: H. McIlleron
Wydane: (2014-04-01)

Pharmacokinetics and pharmacodynamics of curcumin.
od: Sharma, R, i wsp.
Wydane: (2007)

Pharmacokinetics and pharmacodynamics of fosmidomycin monotherapy and combination therapy with clindamycin in the treatment of multidrug resistant falciparum malaria
od: Chauemung Anurak, i wsp.
Wydane: (2007-05-01)

60: PHARMACOKINETICS OF POLYMYXIN B AND THE PHARMACOKINETIC/PHARMACODYNAMIC TARGET ATTAINMENT IN HOSPITALISED ADULT PATIENTS WITH MULTIDRUG-RESISTANT GRAM-NEGATIVE INFECTIONS
od: Puteri Juanita Zamri, Ms, i wsp.
Wydane: (2022-11-01)

Pharmacokinetic-pharmacodynamic modeling and simulation /
od: 192959 Bonate, Peter L.
Wydane: (2005)

Pharmacodynamics and pharmacokinetics of snake antivenom
od: Bhagya Nikapitiya, i wsp.
Wydane: (2018-06-01)

Isavuconazole Pharmacokinetics and Pharmacodynamics in Children
od: Hirsh Elhence, i wsp.
Wydane: (2022-12-01)

The Pharmacokinetics and Pharmacodynamics of Iron Preparations
od: Susanna Burckhardt, i wsp.
Wydane: (2011-01-01)

Minimum inhibitory concentration, pharmacokinetics/pharmacodynamics and therapeutic drug monitoring: An integrated approach for multidrug-resistant tuberculosis
od: Shashikant Srivastava
Wydane: (2015-01-01)

Pharmacodynamic Parameters of Pharmacokinetic/Pharmacodynamic (PK/PD) Integration Models
od: Longfei Zhang, i wsp.
Wydane: (2022-03-01)

Pharmacokinetics and pharmacokinetic/pharmacodynamic integration of danofloxacin in Lohi sheep
od: Z. Manzoor, i wsp.
Wydane: (2020-12-01)

In Vitro ADME, Preclinical Pharmacokinetics and Prediction of Human Pharmacokinetics of RBx14255, a Novel Ketolide with Pharmacodynamics Against Multidrug-Resistant Bacterial Pathogens
od: Trdib Chaira, i wsp.
Wydane: (2020-06-01)

Pharmacokinetic/pharmacodynamic relationships of FTY720 in kidney transplant recipients
od: S.I. Park, i wsp.
Wydane: (2005-05-01)

Clinical pharmacokinetics and pharmacodynamics of artemisinin and derivatives.
od: White, N
Wydane: (1994)

Ketoprofen in the Cat: Pharmacodynamics and Chiral Pharmacokinetics
od: Lees, Peter, i wsp.
Wydane: (2003)

Clinical pharmacokinetics and pharmacodynamics of artemether-lumefantrine
od: White, N, i wsp.
Wydane: (1999)

Zopiclone: some remarks on pharmacokinetics and pharmacodynamics
od: Swiss Medical Weekly
Wydane: (2003-02-01)

The Overview on the Pharmacokinetic and Pharmacodynamic Interactions of Triazoles
od: Andrzej Czyrski, i wsp.
Wydane: (2021-11-01)

Influence of Probenecid on the Pharmacokinetics and Pharmacodynamics of Sorafenib
od: Koen G. A. M. Hussaarts, i wsp.
Wydane: (2020-08-01)

Insights into the Pharmacogenetics of Tacrolimus Pharmacokinetics and Pharmacodynamics
od: Mercè Brunet, i wsp.
Wydane: (2022-08-01)

Pharmacokinetic and pharmacodynamic properties of pantoprazole in calves
od: Jeff D. Olivarez, i wsp.
Wydane: (2023-01-01)

Pharmacokinetics and Pharmacodynamics of Anaesthetic drugs in Paediatrics
od: Rebecca Jacob, i wsp.
Wydane: (2004-01-01)

Oestrogene mimetic isoflavones’ pharmacokinetics and pharmacodynamics
od: Anca Dragomirescu,, i wsp.
Wydane: (2008-12-01)

Measurement of the pharmacokinetics and pharmacodynamics of neuroactive compounds
od: Mohammad S. Alavijeh, i wsp.
Wydane: (2010-01-01)

5613127 PHARMACOKINETICS AND PHARMACODYNAMICS OF AN INNOVATIVE ORAL FORMULATION OF DECITABINE AND TETRAHYDROURIDINE IN HEALTHY PEOPLE
od: Y. Saunthararajah, i wsp.
Wydane: (2023-04-01)

Pharmacokinetic, Pharmacokinetic/Pharmacodynamic, and Safety Investigations of Lefamulin in Healthy Chinese Subjects
od: Yingying Hu, i wsp.
Wydane: (2023-08-01)

Pharmacokinetics, Safety and Pharmacokinetics/Pharmacodynamics Analysis of Omadacycline in Chinese Healthy Subjects
od: Haijing Yang, i wsp.
Wydane: (2022-04-01)

Pharmacokinetics and pharmacodynamics of antimalarial drugs in pregnant women
od: Kloprogge, F
Wydane: (2013)

Pharmacokinetic and pharmacodynamic considerations in antimalarial dose optimization.
od: White, N
Wydane: (2013)